NCT05385692View on ClinicalTrials.gov

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Locally Advanced or Metastatic Digestive Tract TumorsSolid Tumor

Interventions

DRUG

BL-M02D1

Administration by intravenous infusion

Trial Locations (1)

Unknown

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

collaborator

SystImmune Inc.

INDUSTRY

collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY

NCT05385692 - A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors | Biotech Hunter | Biotech Hunter